BIOEQUIVALENCES Meaning and
Definition
-
Bioequivalence is a term used in pharmacology to describe the similarity in terms of bioavailability between different pharmaceutical products containing the same active ingredient. It refers to the equivalence of the concentration of a drug in the blood and tissues after administration of two different formulations that are meant to have the same effect when given in the same dosage.
In order to determine bioequivalence, studies are conducted in which both products are administered to a group of volunteers, and blood samples are taken at various time points to measure the concentration of the drug. Statistical analysis is then performed to compare the pharmacokinetic parameters, such as the area under the concentration-time curve (AUC) and the maximum drug concentration (Cmax), of the two formulations.
The aim of establishing bioequivalence is to ensure that generic versions of drugs are therapeutically equivalent to their brand name counterparts. This allows for the interchangeability of these products and ensures that patients receive the same therapeutic effect when switching between different formulations.
Governments and regulatory authorities, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), have set specific criteria regarding bioequivalence testing that must be met before a generic drug can be approved for sale. These guidelines help ensure the safety and efficacy of generic products and provide assurance to healthcare professionals and patients alike.
Common Misspellings for BIOEQUIVALENCES
- vioequivalences
- nioequivalences
- hioequivalences
- gioequivalences
- buoequivalences
- bjoequivalences
- bkoequivalences
- booequivalences
- b9oequivalences
- b8oequivalences
- biiequivalences
- bikequivalences
- bilequivalences
- bipequivalences
- bi0equivalences
- bi9equivalences
- biowquivalences
- biosquivalences
- biodquivalences
- biorquivalences
Infographic
Add the infographic to your website:
